Healthcare Sector Stocks
The Healthcare sector has a total of 1046 stocks, with a combined market cap of $9.48 trillion, total revenue of $4.73 trillion and a weighted average PE ratio of 44.53.
Market Cap
9.48T
Revenue
4.73T
Profits
212.92B
PE Ratio
44.53
Profit Margin
4.50%
Dividend Yield
0.40%
1046 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.20T | -2.29% | 3,074,579 | 86.46B |
| 2 | JNJ | Johnson & Johnson | 643.09B | -2.04% | 9,825,707 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 501.19B | -0.86% | 4,977,959 | 66.01B |
| 4 | MRK | Merck & Co., Inc. | 327.41B | -3.61% | 13,422,755 | 67.38B |
| 5 | UNH | UnitedHealth Group Incorporated | 296.12B | -5.55% | 19,799,041 | 450.06B |
| 6 | NVS | Novartis AG | 277.60B | -2.57% | 3,548,453 | 57.36B |
| 7 | AZN | AstraZeneca PLC | 272.92B | -1.87% | 2,579,457 | 62.38B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 255.19B | -0.58% | 1,888,320 | 47.35B |
| 9 | AMGN | Amgen Inc. | 237.36B | -1.14% | 2,505,651 | 38.90B |
| 10 | GILD | Gilead Sciences, Inc. | 206.55B | -1.45% | 4,968,157 | 30.99B |
| 11 | ABT | Abbott Laboratories | 179.90B | -0.58% | 7,295,613 | 48.23B |
| 12 | NVO | Novo Nordisk A/S | 173.07B | -1.42% | 16,620,329 | 50.70B |
| 13 | DHR | Danaher Corporation | 160.10B | -0.45% | 4,060,408 | 25.61B |
| 14 | PFE | Pfizer Inc. | 156.97B | -1.85% | 34,993,521 | 63.62B |
| 15 | ISRG | Intuitive Surgical, Inc. | 141.17B | -3.26% | 2,088,960 | 11.58B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 132.01B | -2.94% | 1,152,048 | 12.95B |
| 17 | MDT | Medtronic plc | 123.16B | -0.11% | 5,606,087 | 37.54B |
| 18 | MCK | McKesson Corporation | 122.63B | -2.05% | 611,101 | 418.79B |
| 19 | BMY | Bristol-Myers Squibb Company | 119.25B | -2.05% | 13,551,890 | 50.03B |
| 20 | SYK | Stryker Corporation | 119.19B | -1.59% | 2,195,450 | 26.30B |
| 21 | SNY | Sanofi | 107.70B | -2.25% | 5,393,256 | 57.89B |
| 22 | CVS | CVS Health Corporation | 102.41B | -1.61% | 15,856,971 | 418.16B |
| 23 | HCA | HCA Healthcare, Inc. | 96.16B | -3.36% | 1,415,083 | 78.70B |
| 24 | GSK | GSK plc | 96.01B | -1.56% | 3,333,801 | 44.53B |
| 25 | REGN | Regeneron Pharmaceuticals, Inc. | 92.66B | -2.35% | 718,056 | 16.90B |
| 26 | ELV | Elevance Health, Inc. | 84.30B | -2.66% | 2,726,015 | 201.83B |
| 27 | MRNA | Moderna, Inc. | 80.65B | 1.29% | 8,167,439 | 2.53B |
| 28 | CI | The Cigna Group | 71.95B | -4.32% | 3,650,307 | 286.32B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 69.45B | 0.66% | 5,535,798 | 29.86B |
| 30 | COR | Cencora, Inc. | 65.12B | -2.03% | 1,408,721 | 337.40B |
| 31 | CAH | Cardinal Health, Inc. | 62.95B | -2.15% | 2,035,345 | 257.75B |
| 32 | BSX | Boston Scientific Corporation | 62.31B | -1.49% | 13,558,525 | 21.07B |
| 33 | EW | Edwards Lifesciences Corporation | 59.73B | -1.28% | 3,661,010 | 6.67B |
| 34 | ARGX | argenx SE | 58.96B | 0.08% | 284,162 | 5.92B |
| 35 | BDX | Becton, Dickinson and Company | 57.93B | -1.57% | 2,569,251 | 19.46B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 54.33B | -1.26% | 394,542 | 4.66B |
| 37 | MDLN | Medline Inc. | 49.77B | -3.37% | 10,342,553 | 30.68B |
| 38 | A | Agilent Technologies, Inc. | 49.43B | -1.12% | 2,134,682 | 7.37B |
| 39 | ONC | BeOne Medicines AG | 45.66B | -0.97% | 246,122 | 6.45B |
| 40 | HUM | Humana Inc. | 45.64B | -1.50% | 1,935,413 | 154.19B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 44.97B | -8.74% | 10,340,997 | 17.23B |
| 42 | WAT | Waters Corporation | 44.87B | -2.06% | 1,016,683 | 5.61B |
| 43 | VEEV | Veeva Systems Inc. | 42.57B | -5.15% | 2,951,731 | 3.46B |
| 44 | NTRA | Natera, Inc. | 42.04B | 0.15% | 2,734,687 | 2.91B |
| 45 | IQV | IQVIA Holdings Inc. | 41.29B | -2.83% | 1,410,306 | 17.31B |
| 46 | HLN | Haleon plc | 39.27B | -0.33% | 13,251,350 | 14.80B |
| 47 | RPRX | Royalty Pharma plc | 38.84B | -1.38% | 2,812,956 | 2.62B |
| 48 | GEHC | GE HealthCare Technologies Inc. | 37.03B | -2.12% | 2,835,410 | 21.64B |
| 49 | BIIB | Biogen Inc. | 36.53B | -1.70% | 1,269,175 | 10.30B |
| 50 | ALC | Alcon Inc. | 35.70B | -1.01% | 3,871,455 | 10.98B |
| 51 | RVMD | Revolution Medicines, Inc. | 34.48B | -0.24% | 3,350,784 | 197.56M |
| 52 | MTD | Mettler-Toledo International Inc. | 33.93B | -1.82% | 127,214 | 4.20B |
| 53 | RMD | ResMed Inc. | 33.32B | -2.36% | 1,139,573 | 5.73B |
| 54 | ZTS | Zoetis Inc. | 32.83B | -5.59% | 4,707,298 | 9.49B |
| 55 | GMAB | Genmab A/S | 32.50B | 0.75% | 4,342,442 | 4.30B |
| 56 | CNC | Centene Corporation | 32.47B | -2.77% | 5,531,507 | 180.41B |
| 57 | INSM | Insmed Incorporated | 31.69B | 20.58% | 14,394,643 | 1.52B |
| 58 | ILMN | Illumina, Inc. | 30.34B | -4.45% | 1,627,879 | 4.54B |
| 59 | LH | Labcorp Holdings Inc. | 29.95B | -0.51% | 664,538 | 14.59B |
| 60 | DXCM | DexCom, Inc. | 29.91B | -2.82% | 4,465,618 | 5.10B |
| 61 | PHG | Koninklijke Philips N.V. | 28.72B | -1.88% | 1,510,472 | 20.16B |
| 62 | DGX | Quest Diagnostics Incorporated | 28.50B | -0.23% | 1,108,499 | 11.84B |
| 63 | ROIV | Roivant Sciences Ltd. | 28.23B | 0.59% | 4,930,805 | 41.08M |
| 64 | WST | West Pharmaceutical Services, Inc. | 27.63B | -1.81% | 816,003 | 3.40B |
| 65 | STE | STERIS plc | 24.74B | -1.85% | 881,142 | 6.17B |
| 66 | UTHR | United Therapeutics Corporation | 23.81B | -3.16% | 320,752 | 3.19B |
| 67 | INCY | Incyte Corporation | 23.62B | -1.64% | 1,177,317 | 6.01B |
| 68 | VTRS | Viatris Inc. | 22.79B | -1.97% | 9,086,842 | 14.73B |
| 69 | THC | Tenet Healthcare Corporation | 20.98B | -2.86% | 1,511,683 | 22.15B |
| 70 | BNTX | BioNTech SE | 20.18B | -2.26% | 1,497,506 | 2.75B |
| 71 | ALNY | Alnylam Pharmaceuticals, Inc. | 19.80B | -1.06% | 1,743,614 | 5.01B |
| 72 | GH | Guardant Health, Inc. | 19.70B | 0.31% | 1,869,902 | 1.28B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 19.20B | -1.79% | 1,848,586 | 8.57B |
| 74 | MEDP | Medpace Holdings, Inc. | 17.73B | -1.99% | 167,781 | 2.84B |
| 75 | RVTY | Revvity, Inc. | 16.92B | -0.55% | 1,305,605 | 2.94B |
| 76 | ASND | Ascendis Pharma A/S | 16.79B | -5.32% | 969,867 | 1.37B |
| 77 | EXEL | Exelixis, Inc. | 16.06B | -3.60% | 2,246,236 | 2.50B |
| 78 | NBIX | Neurocrine Biosciences, Inc. | 15.85B | -3.85% | 1,350,816 | 3.70B |
| 79 | CRL | Charles River Laboratories International, Inc. | 15.71B | -1.60% | 495,001 | 3.98B |
| 80 | BBIO | BridgeBio Pharma, Inc. | 15.23B | 0.22% | 2,173,321 | 945.54M |
| 81 | JAZZ | Jazz Pharmaceuticals plc | 15.18B | -4.57% | 1,230,932 | 4.72B |
| 82 | SOLV | Solventum Corporation | 14.56B | -0.79% | 786,480 | 8.16B |
| 83 | ICLR | ICON Public Limited Company | 14.26B | -2.46% | 939,700 | 8.23B |
| 84 | GKOS | Glaukos Corporation | 14.09B | 2.15% | 733,257 | 690.33M |
| 85 | BTSG | BrightSpring Health Services, Inc. | 13.34B | -6.32% | 3,106,285 | 15.25B |
| 86 | ELAN | Elanco Animal Health Incorporated | 13.14B | -1.54% | 7,049,932 | 5.15B |
| 87 | BAX | Baxter International Inc. | 13.14B | -2.94% | 4,670,721 | 11.61B |
| 88 | EHC | Encompass Health Corporation | 12.98B | -1.96% | 1,127,748 | 6.34B |
| 89 | PEN | Penumbra, Inc. | 12.61B | -0.18% | 218,267 | 1.56B |
| 90 | SNN | Smith & Nephew plc | 12.45B | -1.62% | 1,155,530 | 6.30B |
| 91 | RDY | Dr. Reddy's Laboratories Limited | 12.34B | -1.00% | 1,924,112 | 3.44B |
| 92 | BMRN | BioMarin Pharmaceutical Inc. | 11.90B | -0.02% | 5,200,734 | 3.66B |
| 93 | COO | The Cooper Companies, Inc. | 11.47B | -0.69% | 2,095,840 | 4.24B |
| 94 | TECH | Bio-Techne Corporation | 11.42B | -0.07% | 3,322,608 | 1.23B |
| 95 | ALGN | Align Technology, Inc. | 11.26B | -2.61% | 1,198,849 | 4.16B |
| 96 | RGEN | Repligen Corporation | 10.89B | -1.38% | 880,552 | 805.61M |
| 97 | TEM | Tempus AI, Inc. | 10.87B | -6.30% | 5,281,515 | 1.51B |
| 98 | HALO | Halozyme Therapeutics, Inc. | 10.61B | -2.88% | 3,909,484 | 1.80B |
| 99 | MOH | Molina Healthcare, Inc. | 10.59B | -1.56% | 835,635 | 42.08B |
| 100 | FMS | Fresenius Medical Care AG | 10.45B | -3.91% | 2,101,738 | 22.12B |
| 101 | QGEN | Qiagen N.V. | 10.25B | 0.14% | 2,740,918 | 2.12B |
| 102 | AVTR | Avantor, Inc. | 10.25B | -1.63% | 7,026,368 | 6.64B |
| 103 | ENSG | The Ensign Group, Inc. | 10.22B | -3.49% | 386,900 | 5.67B |
| 104 | KYMR | Kymera Therapeutics, Inc. | 10.19B | -1.44% | 723,169 | 102.24M |
| 105 | UHS | Universal Health Services, Inc. | 10.09B | -5.96% | 741,716 | 18.35B |
| 106 | BIO | Bio-Rad Laboratories, Inc. | 9.88B | -0.72% | 424,362 | 2.59B |
| 107 | DVA | DaVita Inc. | 9.84B | -3.37% | 988,307 | 14.17B |
| 108 | PODD | Insulet Corporation | 9.52B | -1.96% | 1,557,095 | 3.19B |
| 109 | BRKR | Bruker Corporation | 9.48B | -1.83% | 1,847,464 | 3.51B |
| 110 | HSIC | Henry Schein, Inc. | 9.37B | -1.04% | 2,046,646 | 13.73B |
| 111 | KRYS | Krystal Biotech, Inc. | 9.36B | 0.15% | 295,865 | 470.03M |
| 112 | SYRE | Spyre Therapeutics, Inc. | 9.27B | -3.77% | 624,446 | - |
| 113 | PCVX | Vaxcyte, Inc. | 9.24B | -0.27% | 981,051 | - |
| 114 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.22B | -0.34% | 416,637 | 1.43B |
| 115 | TGTX | TG Therapeutics, Inc. | 9.09B | -1.88% | 1,440,557 | 897.76M |
| 116 | GMED | Globus Medical, Inc. | 9.09B | -2.74% | 1,281,042 | 3.14B |
| 117 | ATR | AptarGroup, Inc. | 8.90B | -0.94% | 442,803 | 3.99B |
| 118 | HNGE | Hinge Health, Inc. | 8.79B | -5.61% | 1,686,860 | 800.82M |
| 119 | PRAX | Praxis Precision Medicines, Inc. | 8.69B | 1.87% | 630,302 | 7.46M |
| 120 | SMMT | Summit Therapeutics Inc. | 8.45B | 0.67% | 9,006,694 | - |
| 121 | OSCR | Oscar Health, Inc. | 8.12B | -5.08% | 5,569,923 | 17.47B |
| 122 | RYTM | Rhythm Pharmaceuticals, Inc. | 8.10B | -1.88% | 1,106,508 | 280.75M |
| 123 | PTGX | Protagonist Therapeutics, Inc. | 8.09B | -2.47% | 553,969 | 551.69M |
| 124 | HQY | HealthEquity, Inc. | 8.05B | 0.07% | 941,919 | 1.36B |
| 125 | ALKS | Alkermes plc | 7.76B | -1.43% | 1,383,516 | 1.75B |
| 126 | TWST | Twist Bioscience Corporation | 7.61B | -4.07% | 2,252,833 | 459.43M |
| 127 | TXG | 10x Genomics, Inc. | 7.55B | 0.54% | 2,309,636 | 618.58M |
| 128 | AMRX | Amneal Pharmaceuticals, Inc. | 7.45B | -2.24% | 1,579,909 | 3.20B |
| 129 | BLCO | Bausch + Lomb Corporation | 7.40B | -1.24% | 398,073 | 5.42B |
| 130 | KNSA | Kiniksa Pharmaceuticals International, plc | 7.35B | -1.59% | 426,251 | 945.96M |
| 131 | CGON | CG Oncology, Inc. | 7.32B | 2.38% | 2,519,944 | 6.17M |
| 132 | CYTK | Cytokinetics, Incorporated | 7.17B | 0.27% | 1,743,719 | 113.29M |
| 133 | CHE | Chemed Corporation | 7.15B | 0.84% | 236,065 | 2.66B |
| 134 | AXSM | Axsome Therapeutics, Inc. | 7.14B | 1.25% | 639,646 | 865.27M |
| 135 | CORT | Corcept Therapeutics Incorporated | 7.11B | -4.15% | 950,358 | 963.65M |
| 136 | ABVX | ABIVAX Société Anonyme | 7.05B | -3.79% | 2,326,731 | 5.33M |
| 137 | GRFS | Grifols, S.A. | 7.04B | -3.19% | 436,509 | 8.63B |
| 138 | IBRX | ImmunityBio, Inc. | 6.99B | -1.94% | 10,203,632 | 182.57M |
| 139 | PACS | PACS Group, Inc. | 6.83B | -7.06% | 1,607,027 | 5.71B |
| 140 | IMVT | Immunovant, Inc. | 6.73B | -1.96% | 730,786 | - |
| 141 | LNTH | Lantheus Holdings, Inc. | 6.68B | 0.10% | 1,495,714 | 1.56B |
| 142 | ORKA | Oruka Therapeutics, Inc. | 6.62B | 1.91% | 915,746 | - |
| 143 | TFX | Teleflex Incorporated | 6.48B | -1.48% | 926,693 | 2.26B |
| 144 | KOD | Kodiak Sciences Inc. | 6.39B | 0.09% | 521,856 | - |
| 145 | MIRM | Mirum Pharmaceuticals, Inc. | 6.24B | 3.27% | 759,051 | 670.78M |
| 146 | ARWR | Arrowhead Pharmaceuticals, Inc. | 6.17B | 1.25% | 2,555,851 | 450.82M |
| 147 | SRRK | Scholar Rock Holding Corporation | 6.15B | 4.94% | 2,452,798 | 570.00K |
| 148 | BLTE | Belite Bio, Inc | 6.13B | -3.33% | 138,885 | - |
| 149 | SUPN | Supernus, Inc. | 5.89B | -2.11% | 2,400,213 | 1.37B |
| 150 | LGND | Ligand Pharmaceuticals Incorporated | 5.74B | -3.94% | 168,813 | 253.83M |
| 151 | HAE | Haemonetics Corporation | 5.48B | -2.03% | 305,834 | 1.38B |
| 152 | RDNT | RadNet, Inc. | 5.48B | -3.22% | 747,829 | 2.38B |
| 153 | CAI | Caris Life Sciences, Inc. | 5.32B | -4.92% | 3,633,723 | 1.05B |
| 154 | DOCS | Doximity, Inc. | 5.28B | -3.46% | 2,019,026 | 661.58M |
| 155 | MANE | Veradermics, Incorporated | 5.25B | -0.38% | 293,008 | - |
| 156 | CON | Concentra Group Holdings Parent, Inc. | 5.24B | -1.12% | 1,007,253 | 2.34B |
| 157 | WAY | Waystar Holding Corp. | 5.21B | -1.63% | 1,445,074 | 1.26B |
| 158 | LQDA | Liquidia Corporation | 5.10B | 0.41% | 1,341,896 | 621.87M |
| 159 | LIVN | LivaNova PLC | 5.07B | -2.61% | 565,476 | 1.51B |
| 160 | LFST | LifeStance Health Group, Inc. | 5.07B | -3.12% | 4,922,417 | 1.68B |
| 161 | MMSI | Merit Medical Systems, Inc. | 5.06B | -1.77% | 516,809 | 1.61B |
| 162 | ERAS | Erasca, Inc. | 4.99B | 3.34% | 4,118,239 | - |
| 163 | PTCT | PTC Therapeutics, Inc. | 4.87B | -3.16% | 799,670 | 1.16B |
| 164 | COGT | Cogent Biosciences, Inc. | 4.83B | -0.25% | 1,652,532 | - |
| 165 | DNTH | Dianthus Therapeutics, Inc. | 4.78B | 1.01% | 888,420 | 2.72M |
| 166 | OPCH | Option Care Health, Inc. | 4.74B | -0.32% | 2,695,140 | 5.75B |
| 167 | GRAL | GRAIL, Inc. | 4.71B | 2.68% | 787,311 | 166.60M |
| 168 | TVTX | Travere Therapeutics, Inc. | 4.64B | -3.86% | 1,792,704 | 651.03M |
| 169 | SHC | Sotera Health Company | 4.63B | -0.43% | 2,315,143 | 1.23B |
| 170 | MMED | MiniMed Group, Inc. | 4.57B | -4.30% | 6,972,688 | 3.22B |
| 171 | ADPT | Adaptive Biotechnologies Corporation | 4.54B | -1.44% | 1,892,177 | 298.01M |
| 172 | IONS | Ionis Pharmaceuticals, Inc. | 4.53B | -0.62% | 3,059,870 | 960.09M |
| 173 | EWTX | Edgewise Therapeutics, Inc. | 4.51B | -0.48% | 1,188,182 | - |
| 174 | ICUI | ICU Medical, Inc. | 4.40B | -1.52% | 174,630 | 2.18B |
| 175 | STVN | Stevanato Group S.p.A. | 4.35B | 3.71% | 492,562 | 1.42B |
| 176 | BLLN | BillionToOne, Inc. | 4.31B | -1.46% | 914,392 | 436.87M |
| 177 | DFTX | Definium Therapeutics, Inc. | 4.04B | 1.24% | 3,074,004 | - |
| 178 | HTFL | HeartFlow, Inc. | 3.92B | -2.75% | 1,279,640 | 238.66M |
| 179 | TNGX | Tango Therapeutics, Inc. | 3.85B | 3.75% | 1,804,964 | 53.81M |
| 180 | TARS | Tarsus Pharmaceuticals, Inc. | 3.83B | 2.26% | 613,041 | 682.20M |
| 181 | CDNA | CareDx, Inc. | 3.78B | -3.39% | 878,352 | 497.40M |
| 182 | CRSP | CRISPR Therapeutics AG | 3.78B | -3.14% | 4,078,986 | 25.17M |
| 183 | HIMS | Hims & Hers Health, Inc. | 3.76B | -6.04% | 13,420,528 | 2.87B |
| 184 | NVST | Envista Holdings Corporation | 3.73B | -2.02% | 2,450,782 | 2.88B |
| 185 | XENE | Xenon Pharmaceuticals Inc. | 3.69B | -0.50% | 1,281,691 | 7.50M |
| 186 | OGN | Organon & Co. | 3.65B | -0.07% | 3,387,557 | 6.10B |
| 187 | VRDN | Viridian Therapeutics, Inc. | 3.57B | 4.38% | 4,018,084 | 26.31M |
| 188 | RLAY | Relay Therapeutics, Inc. | 3.52B | -3.63% | 1,884,203 | 10.35M |
| 189 | IRON | Disc Medicine, Inc. | 3.47B | -2.40% | 646,409 | - |
| 190 | SGRY | Surgery Partners, Inc. | 3.46B | -1.00% | 2,731,496 | 3.36B |
| 191 | PBLS | Parabilis Medicines, Inc. | 3.46B | -2.97% | 805,678 | 2.26M |
| 192 | ARQT | Arcutis Biotherapeutics, Inc. | 3.44B | -1.59% | 1,330,639 | 508.68M |
| 193 | ABCL | AbCellera Biologics Inc. | 3.42B | -4.99% | 2,477,307 | 67.85M |
| 194 | ELVN | Enliven Therapeutics, Inc. | 3.42B | 3.39% | 993,370 | - |
| 195 | IOVA | Iovance Biotherapeutics, Inc. | 3.38B | -2.27% | 8,531,950 | 378.98M |
| 196 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.37B | -1.58% | 1,760,899 | -665.00K |
| 197 | AXGN | Axogen, Inc. | 3.37B | -1.05% | 1,092,200 | 266.93M |
| 198 | VKTX | Viking Therapeutics, Inc. | 3.30B | -1.26% | 2,760,388 | - |
| 199 | PLSE | Pulse Biosciences, Inc. | 3.27B | -3.10% | 271,600 | 1.49M |
| 200 | TMDX | TransMedics Group, Inc. | 3.27B | -2.50% | 1,004,413 | 727.65M |
| 201 | ACHC | Acadia Healthcare Company, Inc. | 3.20B | -8.30% | 1,917,149 | 3.41B |
| 202 | BHC | Bausch Health Companies Inc. | 3.20B | -1.95% | 3,263,799 | 11.11B |
| 203 | IRTC | iRhythm Holdings, Inc. | 3.17B | -0.66% | 795,224 | 854.04M |
| 204 | PRVA | Privia Health Group, Inc. | 3.15B | 0.37% | 1,729,168 | 2.43B |
| 205 | LEGN | Legend Biotech Corporation | 3.12B | -0.92% | 2,185,931 | 1.36B |
| 206 | ACAD | Acadia Pharmaceuticals Inc. | 3.04B | -1.35% | 1,450,789 | 1.20B |
| 207 | XERS | Xeris Biopharma Holdings, Inc. | 3.04B | -2.18% | 2,563,642 | 368.26M |
| 208 | SLS | SELLAS Life Sciences Group, Inc. | 3.03B | -17.21% | 36,192,955 | - |
| 209 | DYN | Dyne Therapeutics, Inc. | 3.00B | 1.01% | 2,437,391 | - |
| 210 | WRBY | Warby Parker Inc. | 3.00B | -14.49% | 6,611,292 | 934.66M |
| 211 | VCEL | Vericel Corporation | 2.97B | -0.66% | 686,445 | 324.17M |
| 212 | ADMA | ADMA Biologics, Inc. | 2.96B | -1.62% | 3,623,935 | 519.15M |
| 213 | GRDN | Guardian Pharmacy Services, Inc. | 2.96B | -4.44% | 585,255 | 1.46B |
| 214 | NHC | National HealthCare Corporation | 2.95B | -6.47% | 93,461 | 1.58B |
| 215 | DNLI | Denali Therapeutics Inc. | 2.92B | -1.09% | 1,262,835 | 21.38M |
| 216 | TLX | Telix Pharmaceuticals Limited | 2.92B | -2.79% | 217,691 | 890.79M |
| 217 | CELC | Celcuity Inc. | 2.77B | 1.28% | 1,458,040 | - |
| 218 | ATRC | AtriCure, Inc. | 2.76B | -2.42% | 497,675 | 589.80M |
| 219 | MBX | MBX Biosciences, Inc. | 2.65B | -0.02% | 746,728 | - |
| 220 | PGNY | Progyny, Inc. | 2.61B | -1.96% | 932,698 | 1.34B |
| 221 | XNCR | Xencor, Inc. | 2.55B | -1.10% | 1,091,456 | 200.49M |
| 222 | IDYA | IDEAYA Biosciences, Inc. | 2.53B | -1.21% | 1,195,689 | 36.54M |
| 223 | ZLAB | Zai Lab Limited | 2.46B | -0.86% | 577,128 | 441.73M |
| 224 | NEOG | Neogen Corporation | 2.37B | -2.08% | 2,139,165 | 884.00M |
| 225 | HCM | HUTCHMED (China) Limited | 2.35B | -3.86% | 37,528 | 549.12M |
| 226 | PBH | Prestige Consumer Healthcare Inc. | 2.35B | -2.02% | 510,727 | 1.17B |
| 227 | NAMS | NewAmsterdam Pharma Company N.V. | 2.34B | -1.17% | 1,983,802 | 25.94M |
| 228 | AVAH | Aveanna Healthcare Holdings Inc. | 2.34B | -1.34% | 2,282,114 | 2.68B |
| 229 | UFPT | UFP Technologies, Inc. | 2.32B | -2.20% | 105,200 | 649.52M |
| 230 | MD | Pediatrix Medical Group, Inc. | 2.28B | -2.92% | 597,143 | 1.96B |
| 231 | RCUS | Arcus Biosciences, Inc. | 2.27B | 0.13% | 1,074,632 | 100.00M |
| 232 | PHVS | Pharvaris N.V. | 2.24B | 0.35% | 283,855 | - |
| 233 | PRGO | Perrigo Company plc | 2.23B | -5.31% | 1,772,886 | 4.09B |
| 234 | ADUS | Addus HomeCare Corporation | 2.21B | 0.18% | 344,697 | 1.50B |
| 235 | CLDX | Celldex Therapeutics, Inc. | 2.20B | 1.49% | 750,184 | 158.00K |
| 236 | RGC | Regencell Bioscience Holdings Limited | 2.16B | -7.04% | 100,639 | - |
| 237 | LKFT | Lakefront Biotherapeutics NV | 2.15B | -2.00% | 293,194 | 1.13B |
| 238 | PVLA | Palvella Therapeutics, Inc. | 2.13B | -0.55% | 148,412 | - |
| 239 | BEAM | Beam Therapeutics Inc. | 2.09B | -0.33% | 3,294,074 | 146.64M |
| 240 | BKD | Brookdale Senior Living Inc. | 2.08B | 1.16% | 8,210,122 | 2.86B |
| 241 | ESTA | Establishment Labs Holdings Inc. | 2.08B | -1.68% | 396,521 | 264.03M |
| 242 | BHVN | Biohaven Ltd. | 2.06B | 5.81% | 3,261,959 | - |
| 243 | ARDT | Ardent Health, Inc. | 2.04B | 0.69% | 2,193,235 | 6.45B |
| 244 | VCYT | Veracyte, Inc. | 2.02B | -2.07% | 1,874,393 | 581.78M |
| 245 | CLOV | Clover Health Investments, Corp. | 2.02B | -9.59% | 8,321,588 | 2.74B |
| 246 | AUPH | Aurinia Pharmaceuticals Inc. | 2.00B | -1.59% | 968,578 | 321.74M |
| 247 | ALMR | Alamar Biosciences, Inc. | 1.99B | -6.00% | 326,539 | 114.05M |
| 248 | SDGR | Schrödinger, Inc. | 1.98B | -3.16% | 1,447,267 | 269.20M |
| 249 | AZTA | Azenta, Inc. | 1.97B | -3.29% | 1,368,183 | 621.70M |
| 250 | IMNM | Immunome, Inc. | 1.96B | -1.01% | 881,278 | 4.02M |
| 251 | TRVI | Trevi Therapeutics, Inc. | 1.96B | 1.55% | 2,217,308 | - |
| 252 | NEO | NeoGenomics, Inc. | 1.95B | -1.31% | 1,789,287 | 787.75M |
| 253 | FTRE | Fortrea Holdings Inc. | 1.94B | -1.71% | 1,498,410 | 2.67B |
| 254 | HRMY | Harmony Biosciences Holdings, Inc. | 1.94B | -0.39% | 804,704 | 989.36M |
| 255 | VERA | Vera Therapeutics, Inc. | 1.93B | 4.57% | 1,050,253 | 10.28M |
| 256 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.88B | 0.27% | 3,781,734 | 961.51M |
| 257 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.87B | -2.57% | 2,615,469 | 213.00M |
| 258 | TRAX | First Tracks Biotherapeutics, Inc. | 1.87B | -0.09% | 432,353 | - |
| 259 | SEPN | Septerna, Inc. | 1.86B | -0.63% | 209,024 | 96.27M |
| 260 | COAG | Hemab Therapeutics Holdings, Inc. | 1.86B | 1.81% | 248,303 | - |
| 261 | ZYME | Zymeworks Inc. | 1.85B | 3.15% | 992,980 | 265.97M |
| 262 | LYCA | Lycia Therapeutics, Inc. | 1.83B | 1.34% | 281,786 | 4.44M |
| 263 | REPL | Replimune Group, Inc. | 1.82B | -2.93% | 1,687,250 | - |
| 264 | TRLV | Trulieve Cannabis Corp. | 1.80B | -6.69% | 1,750,473 | 1.08B |
| 265 | MAZE | Maze Therapeutics, Inc. | 1.77B | 3.94% | 1,000,423 | 20.00M |
| 266 | ETON | Eton Pharmaceuticals, Inc. | 1.77B | -1.02% | 387,397 | 141.06M |
| 267 | STOK | Stoke Therapeutics, Inc. | 1.76B | 0.90% | 638,935 | 28.21M |
| 268 | RARE | Ultragenyx Pharmaceutical Inc. | 1.75B | -2.88% | 3,118,402 | 730.00M |
| 269 | AGIO | Agios Pharmaceuticals, Inc. | 1.72B | -3.10% | 469,825 | 140.84M |
| 270 | LMAT | LeMaitre Vascular, Inc. | 1.71B | -0.62% | 250,296 | 269.36M |
| 271 | ZBIO | Zenas BioPharma, Inc. | 1.70B | -5.22% | 268,786 | 11.00M |
| 272 | RXRX | Recursion Pharmaceuticals, Inc. | 1.70B | -3.72% | 52,333,364 | 68.23M |
| 273 | XRAY | DENTSPLY SIRONA Inc. | 1.68B | -0.35% | 5,028,743 | 3.58B |
| 274 | HCSG | Healthcare Services Group, Inc. | 1.67B | -1.31% | 629,073 | 1.88B |
| 275 | INSP | Inspire Medical Systems, Inc. | 1.63B | -3.15% | 614,736 | 880.94M |
| 276 | CERT | Certara, Inc. | 1.63B | -4.47% | 1,823,926 | 425.76M |
| 277 | KRSA | Korsana Biosciences, Inc. | 1.61B | 6.55% | 311,239 | - |
| 278 | PSNL | Personalis, Inc. | 1.60B | -1.74% | 2,756,489 | 80.77M |
| 279 | KMTS | Kestra Medical Technologies, Ltd. | 1.59B | -5.87% | 382,492 | 106.73M |
| 280 | ADRX | ADARx Pharmaceuticals, Inc. | 1.57B | 10.45% | 556,340 | 6.13M |
| 281 | BRVE | Braveheart Bio, Inc. | 1.57B | 3.99% | 1,041,405 | - |
| 282 | BFLY | Butterfly Network, Inc. | 1.56B | -3.78% | 4,286,602 | 123.26M |
| 283 | URGN | UroGen Pharma Ltd. | 1.56B | 6.51% | 1,898,380 | 250.25M |
| 284 | SNDA | Sonida Senior Living, Inc. | 1.53B | -2.38% | 456,790 | 593.56M |
| 285 | ALVO | Alvotech | 1.53B | -5.71% | 677,359 | 492.31M |
| 286 | OMCL | Omnicell, Inc. | 1.53B | -4.27% | 437,279 | 1.24B |
| 287 | SRPT | Sarepta Therapeutics, Inc. | 1.52B | -2.48% | 2,069,126 | 1.96B |
| 288 | VIR | Vir Biotechnology, Inc. | 1.52B | -3.06% | 1,886,839 | 302.80M |
| 289 | ENOV | Enovis Corporation | 1.51B | -3.21% | 788,661 | 2.31B |
| 290 | DMRA | Damora Therapeutics, Inc. | 1.50B | 5.74% | 548,783 | - |
| 291 | KLRA | Kailera Therapeutics, Inc. | 1.50B | -1.78% | 473,966 | - |
| 292 | AGL | agilon health, inc. | 1.50B | -1.14% | 403,190 | 6.00B |
| 293 | PGEN | Precigen, Inc. | 1.49B | -2.58% | 4,369,978 | 156.94M |
| 294 | NRIX | Nurix Therapeutics, Inc. | 1.49B | -3.55% | 2,253,858 | 701.94M |
| 295 | PRCT | PROCEPT BioRobotics Corporation | 1.48B | 2.26% | 1,506,144 | 352.31M |
| 296 | WGS | GeneDx Holdings Corp. | 1.48B | -5.23% | 792,789 | 460.78M |
| 297 | NBTX | Nanobiotix S.A. | 1.47B | 1.54% | 177,329 | 13.15M |
| 298 | ASTH | Astrana Health, Inc. | 1.47B | -3.27% | 369,634 | 3.91B |
| 299 | ANIP | ANI Pharmaceuticals, Inc. | 1.46B | -3.27% | 264,289 | 1.04B |
| 300 | TDOC | Teladoc Health, Inc. | 1.42B | -3.35% | 4,624,749 | 2.47B |
| 301 | MESO | Mesoblast Limited | 1.42B | -3.95% | 262,556 | 120.25M |
| 302 | QURE | uniQure N.V. | 1.42B | -0.34% | 1,157,533 | 20.17M |
| 303 | ABSI | Absci Corporation | 1.41B | -0.24% | 4,466,490 | 1.49M |
| 304 | ANAB | AnaptysBio, Inc. | 1.41B | 0.72% | 507,006 | 60.04M |
| 305 | USPH | U.S. Physical Therapy, Inc. | 1.41B | -1.16% | 301,242 | 829.86M |
| 306 | SVRA | Savara Inc. | 1.40B | 10.38% | 12,250,965 | - |
| 307 | RAPP | Rapport Therapeutics, Inc. | 1.40B | 0.81% | 300,932 | 20.00M |
| 308 | WWB | Windward Bio Group AG | 1.39B | 6.05% | 166,311 | - |
| 309 | PAHC | Phibro Animal Health Corporation | 1.38B | -4.19% | 101,713 | 1.54B |
| 310 | CNMD | CONMED Corporation | 1.38B | -3.40% | 437,111 | 1.37B |
| 311 | IMCR | Immunocore Holdings plc | 1.38B | -3.20% | 372,932 | 429.30M |
| 312 | TYRA | Tyra Biosciences, Inc. | 1.36B | 0.61% | 287,720 | - |
| 313 | ALHC | Alignment Healthcare, Inc. | 1.36B | -3.27% | 3,574,858 | 4.94B |
| 314 | LMRI | Lumexa Imaging Holdings, Inc. | 1.35B | 0.36% | 339,800 | 1.06B |
| 315 | NUVB | Nuvation Bio Inc. | 1.34B | 0.79% | 9,412,345 | 201.73M |
| 316 | GENB | Generate Biomedicines, Inc. | 1.34B | -0.10% | 835,362 | 21.07M |
| 317 | NTLA | Intellia Therapeutics, Inc. | 1.34B | -2.56% | 9,954,219 | 52.89M |
| 318 | AMN | AMN Healthcare Services, Inc. | 1.32B | -8.64% | 701,199 | 3.52B |
| 319 | INVA | Innoviva, Inc. | 1.31B | 0.05% | 837,533 | 438.32M |
| 320 | LBRX | LB Pharmaceuticals Inc | 1.30B | -0.05% | 404,410 | - |
| 321 | OCUL | Ocular Therapeutix, Inc. | 1.29B | -1.35% | 3,080,747 | 50.38M |
| 322 | AVLN | Avalyn Pharma Inc. | 1.28B | 3.65% | 437,290 | - |
| 323 | GHRS | GH Research PLC | 1.27B | 1.70% | 275,956 | - |
| 324 | NVAX | Novavax, Inc. | 1.27B | -3.02% | 4,003,072 | 411.65M |
| 325 | MNKD | MannKind Corporation | 1.27B | -2.95% | 4,064,503 | 413.37M |
| 326 | STAA | STAAR Surgical Company | 1.26B | -1.26% | 557,780 | 328.27M |
| 327 | MLYS | Mineralys Therapeutics, Inc. | 1.25B | 2.76% | 1,171,698 | - |
| 328 | NVCR | NovoCure Limited | 1.25B | -0.37% | 1,596,331 | 725.39M |
| 329 | SLN | Silence Therapeutics plc | 1.23B | -0.05% | 145,439 | 456.00K |
| 330 | TSHA | Taysha Gene Therapies, Inc. | 1.23B | -5.51% | 2,174,085 | 5.49M |
| 331 | CMPS | COMPASS Pathways plc | 1.23B | 6.53% | 2,894,739 | - |
| 332 | GPCR | Structure Therapeutics Inc. | 1.23B | -1.38% | 586,203 | - |
| 333 | INNV | InnovAge Holding Corp. | 1.22B | 0.00% | 747,565 | 1.02B |
| 334 | HROW | Harrow, Inc. | 1.21B | -0.09% | 761,802 | 303.25M |
| 335 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.20B | -5.39% | 662,493 | 745.79M |
| 336 | PNTG | The Pennant Group, Inc. | 1.20B | -4.80% | 659,252 | 1.17B |
| 337 | OPK | OPKO Health, Inc. | 1.20B | -4.73% | 2,126,730 | 654.10M |
| 338 | TNDM | Tandem Diabetes Care, Inc. | 1.17B | -1.47% | 2,295,261 | 1.08B |
| 339 | KARD | Kardigan, Inc. | 1.17B | 1.62% | 977,804 | - |
| 340 | VOR | Vor Biopharma Inc. | 1.14B | 3.87% | 726,755 | - |
| 341 | CRON | Cronos Group Inc. | 1.14B | -2.84% | 1,463,007 | 206.20M |
| 342 | NKTR | Nektar Therapeutics | 1.11B | -5.46% | 856,859 | 52.19M |
| 343 | NUTX | Nutex Health Inc. | 1.11B | -6.16% | 105,019 | 796.53M |
| 344 | AAPG | Ascentage Pharma Group International | 1.10B | -4.40% | 1,487 | 94.61M |
| 345 | INBX | Inhibrx Biosciences, Inc. | 1.10B | 7.63% | 420,893 | 2.00M |
| 346 | AHG | Akso Health Group | 1.10B | -5.79% | 4,139 | 13.83M |
| 347 | SIBN | SI-BONE, Inc. | 1.07B | 0.89% | 745,377 | 220.65M |
| 348 | ATEC | Alphatec Holdings, Inc. | 1.07B | -2.27% | 2,655,355 | 839.72M |
| 349 | FRNM | Freenome, Inc. | 1.07B | 2.00% | 875,403 | 217.86M |
| 350 | ANRO | Alto Neuroscience, Inc. | 1.06B | 2.32% | 573,015 | - |
| 351 | IART | Integra LifeSciences Holdings Corporation | 1.05B | -2.24% | 420,089 | 1.66B |
| 352 | DRTS | Alpha Tau Medical Ltd. | 1.04B | -5.83% | 1,245,904 | - |
| 353 | OMER | Omeros Corporation | 1.04B | -3.71% | 1,286,371 | 74.36M |
| 354 | JBIO | Jade Biosciences, Inc. | 1.04B | -2.78% | 508,638 | - |
| 355 | IRMD | IRADIMED CORPORATION | 1.04B | -1.28% | 109,917 | 89.34M |
| 356 | GDRX | GoodRx Holdings, Inc. | 1.03B | -10.12% | 2,161,123 | 785.23M |
| 357 | SGP | SpyGlass Pharma, Inc. | 1.03B | 3.71% | 86,422 | - |
| 358 | CSTL | Castle Biosciences, Inc. | 1.03B | 0.07% | 482,429 | 377.13M |
| 359 | CBLL | CeriBell, Inc. | 1.00B | 0.47% | 537,236 | 108.72M |
| 360 | SPTX | Seaport Therapeutics, Inc. | 980.68M | 0.05% | 321,041 | - |
| 361 | AHCO | AdaptHealth Corp. | 968.53M | -1.63% | 1,705,884 | 3.44B |
| 362 | MLTX | MoonLake Immunotherapeutics | 938.73M | 2.22% | 1,412,943 | - |
| 363 | AKTS | Aktis Oncology, Inc. | 915.08M | 1.86% | 384,783 | 12.39M |
| 364 | CTY | City Therapeutics, Inc. | 913.04M | 10.28% | 245,887 | 14.34M |
| 365 | IMTX | Immatics N.V. | 905.99M | -2.46% | 912,895 | 49.33M |
| 366 | GMRS | GMR Solutions Inc. | 904.89M | -6.54% | 880,480 | 5.97B |
| 367 | AORT | Artivion, Inc. | 904.07M | -0.05% | 814,613 | 481.88M |
| 368 | ODTX | Odyssey Therapeutics, Inc. | 879.24M | -3.37% | 363,864 | 99.00K |
| 369 | LTGO | Latigo Biotherapeutics, Inc. | 877.80M | -0.53% | 130,251 | - |
| 370 | VSTM | Verastem, Inc. | 864.46M | -0.15% | 3,722,952 | 100.30M |
| 371 | KIDS | OrthoPediatrics Corp. | 848.85M | 2.72% | 200,522 | 264.14M |
| 372 | PHAR | Pharming Group N.V. | 844.83M | -2.51% | 10,591 | 386.75M |
| 373 | CRVS | Corvus Pharmaceuticals, Inc. | 844.37M | -1.77% | 704,705 | - |
| 374 | BVS | Bioventus Inc. | 838.40M | -6.31% | 571,971 | 585.64M |
| 375 | IVA | Inventiva S.A. | 835.32M | 1.77% | 2,953,838 | 2.81M |
| 376 | CTKB | Cytek Biosciences, Inc. | 826.55M | 6.76% | 2,180,718 | 207.65M |
| 377 | SNDX | Syndax Pharmaceuticals, Inc. | 821.96M | 6.66% | 3,301,399 | 289.68M |
| 378 | MTRI | Mentari Therapeutics, Inc. | 805.15M | -0.26% | 21,104 | - |
| 379 | HSTM | HealthStream, Inc. | 803.81M | -3.46% | 342,530 | 327.95M |
| 380 | ORIC | ORIC Pharmaceuticals, Inc. | 800.27M | 0.65% | 1,065,903 | - |
| 381 | MGTX | MeiraGTx Holdings plc | 795.53M | -2.16% | 964,916 | 401.91M |
| 382 | BBTX | Bambusa Therapeutics, Inc. | 792.15M | -2.20% | 138,820 | - |
| 383 | COLL | Collegium Pharmaceutical, Inc. | 783.41M | -2.78% | 445,864 | 815.19M |
| 384 | IRWD | Ironwood Pharmaceuticals, Inc. | 779.74M | -1.46% | 3,291,956 | 400.30M |
| 385 | RIGL | Rigel Pharmaceuticals, Inc. | 775.61M | -3.15% | 300,300 | 288.21M |
| 386 | OMDA | Omada Health, Inc. | 775.47M | -5.09% | 1,334,164 | 333.04M |
| 387 | ARDX | Ardelyx, Inc. | 769.20M | -1.92% | 3,385,559 | 468.22M |
| 388 | VREX | Varex Imaging Corporation | 764.56M | -0.06% | 607,326 | 865.00M |
| 389 | GLUE | Monte Rosa Therapeutics, Inc. | 761.36M | -1.76% | 926,178 | 70.33M |
| 390 | OBX | Obsidian Therapeutics, Inc. | 750.54M | -0.49% | 325,392 | - |
| 391 | LXRX | Lexicon Pharmaceuticals, Inc. | 743.54M | -2.91% | 1,383,065 | 38.54M |
| 392 | PHR | Phreesia, Inc. | 736.78M | -3.18% | 608,316 | 507.79M |
| 393 | OABI | OmniAb, Inc. | 733.68M | -0.98% | 1,601,498 | 40.21M |
| 394 | INMD | InMode Ltd. | 730.01M | -1.40% | 550,256 | 373.60M |
| 395 | AURA | Aura Biosciences, Inc. | 726.44M | -2.24% | 495,305 | - |
| 396 | BBNX | Beta Bionics, Inc. | 724.17M | -7.05% | 2,276,030 | 127.27M |
| 397 | SLDB | Solid Biosciences Inc. | 718.77M | 1.42% | 1,739,431 | - |
| 398 | APMD | Apnimed, Inc. | 717.92M | -1.17% | 197,615 | 108.80M |
| 399 | ATTO | Attovia Therapeutics, Inc. | 712.20M | 0.32% | 159,315 | 1.44M |
| 400 | FLGT | Fulgent Genetics, Inc. | 692.33M | -1.39% | 277,977 | 330.28M |
| 401 | SGMT | Sagimet Biosciences Inc. | 686.56M | -4.85% | 1,026,646 | - |
| 402 | PRME | Prime Medicine, Inc. | 685.24M | 0.52% | 3,987,058 | 7.06M |
| 403 | NVCT | Nuvectis Pharma, Inc. | 682.28M | -2.22% | 156,978 | - |
| 404 | IAM | Iambic Therapeutics, Inc. | 675.94M | -3.39% | 297,744 | 18.25M |
| 405 | KURA | Kura Oncology, Inc. | 675.31M | 0.14% | 1,655,504 | 79.31M |
| 406 | DCTH | Delcath Systems, Inc. | 669.32M | -2.34% | 459,621 | 109.96M |
| 407 | ANNX | Annexon, Inc. | 650.51M | -3.12% | 3,149,146 | - |
| 408 | QUIT | Achieve Life Sciences, Inc. | 645.90M | -0.84% | 945,858 | - |
| 409 | JANX | Janux Therapeutics, Inc. | 629.58M | -0.19% | 651,228 | 23.29M |
| 410 | OLMA | Olema Oncology, Inc. | 626.38M | 1.27% | 1,322,152 | - |
| 411 | ABUS | Arbutus Biopharma Corporation | 623.90M | -0.97% | 2,435,771 | 181.49M |
| 412 | QDEL | QuidelOrtho Corporation | 612.02M | -6.79% | 1,915,581 | 2.59B |
| 413 | BCAX | Bicara Therapeutics Inc. | 605.45M | -2.77% | 844,509 | - |
| 414 | FDMT | 4D Molecular Therapeutics, Inc. | 604.39M | 2.49% | 755,230 | 96.06M |
| 415 | DSGN | Design Therapeutics, Inc. | 596.82M | -1.58% | 266,461 | - |
| 416 | DBVT | DBV Technologies S.A. | 596.02M | -2.69% | 243,977 | 3.74M |
| 417 | SGHT | Sight Sciences, Inc. | 590.25M | -1.39% | 383,284 | 88.40M |
| 418 | IMMX | Immix Biopharma, Inc. | 590.04M | -0.98% | 1,133,197 | - |
| 419 | CGEM | Cullinan Therapeutics, Inc. | 588.83M | 0.67% | 999,856 | - |
| 420 | GERN | Geron Corporation | 588.19M | -7.86% | 19,640,140 | 217.52M |
| 421 | SRZN | Surrozen, Inc. | 584.62M | -3.37% | 91,674 | 10.53M |
| 422 | ANL | Adlai Nortye Group Ltd. | 583.45M | 3.66% | 216,070 | 18.06M |
| 423 | AVBP | ArriVent BioPharma, Inc. | 582.40M | 3.30% | 906,598 | 5.00M |
| 424 | TCMD | Tactile Systems Technology, Inc. | 582.21M | -1.63% | 217,821 | 356.42M |
| 425 | SOPH | SOPHiA GENETICS SA | 572.20M | -10.58% | 1,582,118 | 90.97M |
| 426 | ENTX | Entera Bio Ltd. | 571.17M | 0.61% | 229,948 | 42.00K |
| 427 | ALMS | Alumis Inc. | 562.12M | -1.48% | 1,223,192 | 7.24M |
| 428 | ETRA | Electra Therapeutics, Inc. | 561.14M | 6.05% | 390,470 | - |
| 429 | ACRS | Aclaris Therapeutics, Inc. | 555.14M | 0.00% | 1,894,247 | 6.40M |
| 430 | CBIO | Crescent Biopharma, Inc. | 552.56M | 4.11% | 262,059 | 15.00M |
| 431 | OBIO | Orchestra BioMed Holdings, Inc. | 550.93M | -6.17% | 479,793 | 31.21M |
| 432 | PACB | Pacific Biosciences of California, Inc. | 550.75M | -3.83% | 19,998,814 | 161.39M |
| 433 | CLYM | Climb Bio, Inc. | 545.09M | -0.22% | 586,596 | - |
| 434 | ZVRA | Zevra Therapeutics, Inc. | 539.71M | -2.26% | 670,291 | 147.76M |
| 435 | WVE | Wave Life Sciences, Inc. | 536.46M | -1.81% | 1,923,644 | 70.92M |
| 436 | EVO | Evotec SE | 532.60M | -0.68% | 75,302 | 815.72M |
| 437 | DNA | Ginkgo Bioworks Holdings, Inc. | 531.50M | -2.84% | 2,438,791 | 130.75M |
| 438 | MYGN | Myriad Genetics, Inc. | 531.41M | 0.18% | 1,168,021 | 803.60M |
| 439 | NRC | NRC Health | 530.33M | -4.47% | 107,487 | 143.79M |
| 440 | SANA | Sana Biotechnology, Inc. | 521.36M | -5.95% | 3,747,584 | - |
| 441 | VALN | Valneva SE | 509.72M | 0.47% | 1,503 | 163.30M |
| 442 | RCEL | AVITA Medical, Inc. | 506.69M | -4.99% | 362,549 | 84.68M |
| 443 | AVR | Anteris Technologies Global Corp. | 496.24M | -2.30% | 1,255,661 | 2.33M |
| 444 | HELP | Helus Pharma Inc. | 495.35M | -1.60% | 1,997,955 | - |
| 445 | GYRE | Gyre Therapeutics, Inc. | 494.72M | 4.15% | 268,927 | 110.06M |
| 446 | TKNO | Alpha Teknova, Inc. | 491.27M | -0.89% | 266,843 | 45.95M |
| 447 | SENS | Senseonics Holdings, Inc. | 487.82M | -8.57% | 1,319,835 | 60.01M |
| 448 | INDP | Indaptus Therapeutics, Inc. | 480.71M | -4.86% | 101,970 | - |
| 449 | MNPR | Monopar Therapeutics Inc. | 476.34M | -0.65% | 116,474 | - |
| 450 | FENC | Fennec Pharmaceuticals Inc. | 474.85M | 0.90% | 460,107 | 66.37M |
| 451 | RGNX | REGENXBIO Inc. | 474.76M | -1.10% | 807,428 | 153.91M |
| 452 | NGNE | Neurogene Inc. | 474.67M | -0.91% | 149,845 | 925.00K |
| 453 | CARL | Carlsmed, Inc. | 471.90M | -0.86% | 78,484 | 71.78M |
| 454 | AQST | Aquestive Therapeutics, Inc. | 465.67M | -1.98% | 1,434,441 | 48.84M |
| 455 | STTK | Shattuck Labs, Inc. | 463.38M | 1.79% | 1,386,125 | 1.00M |
| 456 | EOLS | Evolus, Inc. | 463.32M | -0.99% | 870,972 | 325.47M |
| 457 | ASMB | Assembly Biosciences, Inc. | 460.74M | 0.49% | 268,374 | 67.01M |
| 458 | OCS | Oculis Holding AG | 459.29M | 0.68% | 153,467 | 1.12M |
| 459 | BLSM | BlossomHill Therapeutics, Inc. | 458.02M | -1.23% | 215,242 | - |
| 460 | MDXG | MiMedx Group, Inc. | 453.83M | -2.20% | 2,019,670 | 303.73M |
| 461 | ANGO | AngioDynamics, Inc. | 452.51M | -4.95% | 612,472 | 325.38M |
| 462 | CTMX | CytomX Therapeutics, Inc. | 446.91M | 9.04% | 5,173,650 | 14.03M |
| 463 | KMDA | Kamada Ltd. | 445.15M | -1.26% | 158,515 | 196.87M |
| 464 | OVID | Ovid Therapeutics Inc. | 441.63M | 3.54% | 1,765,325 | 1.45M |
| 465 | ARVN | Arvinas, Inc. | 441.37M | -0.37% | 843,486 | 275.30M |
| 466 | RZLT | Rezolute, Inc. | 440.59M | -1.18% | 2,371,426 | - |
| 467 | CAPR | Capricor Therapeutics, Inc. | 437.81M | -6.23% | 7,670,220 | 11.13M |
| 468 | IRLA | IRulya Therapeutics Inc. | 433.01M | -1.60% | 106,440 | - |
| 469 | DMAC | DiaMedica Therapeutics Inc. | 432.74M | -6.64% | 374,514 | - |
| 470 | TVGN | Tevogen Inc. | 432.68M | 2.61% | 7,176 | - |
| 471 | SRTA | Strata Critical Medical, Inc. | 431.41M | -2.62% | 1,281,673 | 280.76M |
| 472 | PRTA | Prothena Corporation plc | 431.34M | 0.60% | 566,979 | 52.74M |
| 473 | SI | Shoulder Innovations, Inc. | 424.94M | -1.65% | 121,848 | 64.49M |
| 474 | TECX | Tectonic Therapeutic, Inc. | 411.32M | 0.00% | 73,290 | - |
| 475 | EPRX | Eupraxia Pharmaceuticals Inc. | 409.83M | -1.45% | 739,054 | - |
| 476 | CRMD | CorMedix Inc. | 404.05M | 12.89% | 3,546,953 | 412.49M |
| 477 | PHAT | Phathom Pharmaceuticals, Inc. | 403.50M | -4.15% | 1,034,034 | 274.88M |
| 478 | CADL | Candel Therapeutics, Inc. | 402.43M | -3.57% | 1,188,486 | - |
| 479 | MOBI | Mobia Medical, Inc. | 395.27M | -8.98% | 145,720 | 51.89M |
| 480 | IRD | Opus Genetics, Inc. | 394.35M | 4.08% | 585,225 | 7.91M |
| 481 | AVTX | Avalo Therapeutics, Inc. | 390.31M | 0.75% | 710,330 | 59.00K |
| 482 | MASS | 908 Devices Inc. | 389.63M | -1.58% | 253,087 | 65.79M |
| 483 | EVH | Evolent Health, Inc. | 387.95M | -12.72% | 3,235,353 | 2.34B |
| 484 | CERS | Cerus Corporation | 383.71M | -2.06% | 6,694,776 | 226.57M |
| 485 | PBYI | Puma Biotechnology, Inc. | 368.09M | -1.39% | 469,418 | 231.83M |
| 486 | MPLT | MapLight Therapeutics, Inc. | 360.85M | -3.46% | 381,158 | - |
| 487 | ASPE | Aspen Neuroscience, Inc. | 360.28M | 3.16% | 289,292 | - |
| 488 | CTNM | Contineum Therapeutics, Inc. | 354.96M | -2.16% | 159,511 | - |
| 489 | BWAY | BrainsWay Ltd. | 351.93M | -2.78% | 119,317 | 60.70M |
| 490 | EMBC | Embecta Corp. | 350.72M | 1.64% | 835,446 | 1.02B |
| 491 | ALEC | Alector, Inc. | 342.42M | -10.51% | 1,440,740 | 173.47M |
| 492 | LRMR | Larimar Therapeutics, Inc. | 338.53M | -0.16% | 1,097,712 | - |
| 493 | CV | CapsoVision, Inc. | 338.28M | -7.48% | 169,659 | 13.92M |
| 494 | SPRY | ARS Pharmaceuticals, Inc. | 337.78M | -8.94% | 3,647,363 | 122.14M |
| 495 | PRLD | Prelude Therapeutics Incorporated | 336.12M | -1.36% | 200,815 | 21.57M |
| 496 | LYEL | Lyell Immunopharma, Inc. | 333.87M | -2.23% | 144,167 | 15.00K |
| 497 | RLMD | Relmada Therapeutics, Inc. | 331.82M | 8.93% | 1,708,620 | - |
| 498 | SLBT | SL Science Holding Limited | 331.44M | -11.93% | 44,332 | 3.27M |
| 499 | VMD | Viemed Healthcare, Inc. | 326.26M | -1.94% | 165,822 | 310.37M |
| 500 | CTEV | Claritev Corporation | 324.93M | -14.66% | 271,026 | 1.02B |